Promoter Hypermethylation in MLL-Rearranged Leukemias: Biology and Therapeutic Targeting |
The Johns Hopkins University School of Medicine / Eric Schafer |
Young Investigator Grants |
2010 |
Maryland |
Predicting Outcome for Patients with Metastatic Neuroblastoma by Analysis of Bone Marrow and Blood for a Neuroblastoma Gene Expression Signature |
Children’s Hospital Los Angeles / Robert Seeger |
Innovation Grants |
2010 |
California |
Identification of Novel Treatment Targets by Exploring the Interaction of Rhabdomyosarcoma-Associated Oncogenes with Cellular Context in a Mouse Model of Rhabdomyosarcoma |
Dana-Farber Cancer Institute / Simone Hettmer |
Young Investigator Grants |
2010 |
Massachusetts |
Novel Therapeutic Target in Leukemia Stem Cells |
Cincinnati Children's Hospital Medical Center / James Mulloy |
Innovation Grants |
2010 |
Ohio |
Single Cell Signaling Profiles In High-Risk Pediatric Leukemia |
Stanford University / Kara Davis |
Young Investigator Grants |
2010 |
California |
A novel compound for treatment of T cell leukemia |
Huntsman Cancer Institute / Nikolaus Trede |
Innovation Grants |
2010 |
Utah |
Identification of FDA approved drugs with anti-tumor activity in rhabdomyosarcoma.
|
Massachusetts General Hospital / David Langenau |
Young Investigator Grants |
2009 |
Massachusetts |
Investigating the role of lin-28 in germ cell tumorigenesis
|
Boston Children’s Hospital / George Daley |
Innovation Grants |
2009 |
Massachusetts |
Genetic Regulators of ER Stress-induced Apoptosis in Pediatric Malignancies
|
Dana-Farber Cancer Institute / Ujwal Pyati |
Young Investigator Grants |
2009 |
Massachusetts |
MLL-based chromosomal translocations in the pathogenesis of childhood leukemia.
|
Children’s Mercy / Erin Guest |
Young Investigator Grants |
2009 |
Missouri |